complications, being able to talk, walk, and eat before symptoms of hyponatraemic encephalopathy develop. 1 Treatment is simple and should be prompt: the risk of not treating acute cerebral oedema far exceeds the small risk of osmotic demyelination from treatment. 1 6 Fluid infusions should be restricted to normal or hypertonic saline and sodium concentrations monitored every two hours. 1 5 6 The aim is to raise serum sodium by 1-2 mmol/l per hour (depending on the severity of neurological symptoms) until symptoms resolve. 1 6 A loop diuretic such as frusemide (furosemide) may be used to enhance free water excretion and hasten the restoration of normal sodium concentrations. 1 6 Iatrogenic hyponatraemia is inexcusable. It is time that doctors woke up to the risks.
Dietary management of hepatic encephalopathy
Too many myths persist M yths are difficult to dispel and may delay good evidence based clinical practice. This is illustrated well by a paper in this week's issue on the dietary management of hepatic encephalopathy in patients with cirrhosis (p 1391). 1 Protein restriction in symptomatic patients with hepatic encephalopathy has been the cornerstone of treatment since the 1950s, 2 yet there is no evidence that it has any clinical benefit.
Hepatic encephalopathy is a syndrome of impaired mental status and abnormal neuromuscular function which results from major failure of liver function. Important factors contributing to it are the degree of hepatocellular failure, portosystemic shunting, and exogenous factors such as sepsis and variceal bleeding. 3 The pathogenesis of the syndrome is still uncertain, although current hypotheses include impaired hepatic detoxification of ammonia absorbed from the gut 4 and an increase in aromatic amines, which are precursors for false transmitters in the brain-for example, octopamine-and which alter the balance between neuronal excitation and neuronal inhibition. 5 Furthermore, increased expression of benzodiazepine receptors in hepatocellular failure suggests that the -aminobutyric acid-benzodiazepine inhibitory neurotransmitter system may be implicated in the development of hepatic encephalopathy. 6 Protein restriction as a treatment conveniently began with 20 g protein/day and, with clinical recovery, 10 g increments were introduced every 3-5 days, as tolerated by the patient, to a limit of 0.8-1.0 g/kg body weight 3 ; this was considered sufficient to achieve a positive nitrogen balance. This practice continues despite evidence showing that patients with stable cirrhosis have a higher protein requirement than normal, around 1.2 g/kg dry body weight to remain in positive balance. 7 Protein energy malnutrition, defined by anthropometric criteria, may occur in 20-60% of patients with cirrhosis depending on the severity of the liver disease. 8 It is a common finding, with causative factors which include anorexia, nausea, malabsorption, and a hypermetabolic state. Intake may be further reduced by use of unpalatable low protein diets, already restricted in sodium and fluid.
In 1997 the European Society for Parenteral and Enteral Nutrition published consensus guidelines recommending that the daily protein intake in patients with liver disease should, if possible, be around 1.0-1.5 g/kg depending on the degree of hepatic decompensation. 7 The guidelines also recommended that in patients who were intolerant of dietary protein 0.5 g protein/kg should be used transiently and that the remainder of their requirements should be achieved by giving branched chain amino acids. 9 However, not all studies agree on the use of branched chain amino acids. 10 Furthermore, aggressive enteral nutritional support of patients with alcoholic liver disease accelerates improvement without exacerbating hepatic encephalopathy. 11 Taking smaller meals more often and eating a late evening meal also improve nitrogen balance without exacerbating hepatic encephalopathy. 12 This may also be achieved with vegetable protein as opposed to animal proteins. 13 The dilemma for the clinician arises in patients with acute hepatic encephalopathy, where increasing protein intake may worsen the condition in 35% of patients. 4 Use of branched chain amino acids may improve nitrogen balance but without producing any clinical improvement in the encephalopathy. 9 However, there is no consensus about the rate at which dietary protein should be reintroduced and at what clinical stage this is appropriate-the key points for the clinician.
Soulsby and Morgan provide recent evidence of perpetuation of the myth of protein restriction in patients with encephalopathy and, perhaps more alarmingly, that this therapy is used in patients with cirrhosis who have no neuropsychiatric impairment. 1 We BMJ VOLUME 318 22 MAY 1999 www.bmj.com on 14 November 2005 bmj.com Downloaded from agree with them on the importance of following evidence based guidelines in the dietary and medical management of cirrhotic patients and on the need for a combined approach from hepatologists and specialist dietitians to achieve nitrogen balance without exacerbating neurological symptoms. Furthermore, we need clinical trials to determine markers for assessing when patients should restrict their protein intake and when and at what rate they should return to a more normal diet and maintain nitrogen balance without exacerbating neurological symptoms. At the current state of knowledge it seems sensible to give as much protein (up to 1.5 g/day) to maintain a good nutritional state-a lesson learnt in the dietary management of chronic renal failure 20 years ago. 14 
Carol A Seymour Professor of clinical biochemistry and metabolic medicine Kevin Whelan Gastroenterological dietitian

New rules for expert witnesses
The last shots of the medicolegal hired gun T hose clinicians who provide reports for use in the civil courts of England and Wales will find their practice changing over the next few months. There are fresh opportunities for those new to medicolegal work to take on stimulating (and well paid) work, but clinicians with established practices may well lose out.
The civil justice system in England and Wales has just undergone an upheaval. The changes began in 1994 when Lord Woolf was appointed to review the rules and procedures of the civil courts in England and Wales. The aims of the review were (principally) to improve access to justice and to reduce the costs of litigation. Lord Woolf was particularly troubled by the escalating cost of expert witnesses and the delay caused by the need to engage experts. 1 Although Lord Woolf did not target clinical experts specifically, he complained in his final report that experts had become partisan advocates rather than neutral givers of opinions. 2 The Woolf reports have crystallised into a new set of procedural rules which came into force in April. The basic premise of these rules is that the expert's function is to help the court, not to advance the case of the side by whom he or she is paid.
There are four main areas in which a clinical expert's practice will change. The first is that clinical experts will increasingly be appointed, not by one side or by the other, but jointly (either with the parties' agreement or at the direction of the court). Established experts strongly allied to one side or the other are unlikely to be in demand for this neutral role; conversely, experienced clinicians fresh to medicolegal practice may find themselves well received.
Secondly, the content of clinical reports prepared for the courts will be standardised (the details are available on the BMJ's website). The most noticeable change is that clinicians will have to set out not only their own professional views, but also those of any other "relevant recognised body of opinion." This is likely to make the writing of medicolegal reports a lengthier and more demanding process, especially in view of the fact that the courts now expect reports to be well referenced and logical. 3 Thirdly, the volume of work available for experts is likely to shrink. Expert evidence will only be received by the courts if it is reasonably required to resolve the issues before the court. Severe cost sanctions will discourage the indiscriminate instruction of experts. A further factor reducing the amount of work available is that most evidence will be put to the court in writing: oral evidence from an expert is likely to be the exception rather than the rule.
Fourthly, fees for medicolegal work are likely to fall. The new rules introduce the concept of "proportionality." This is a nebulous concept, but essentially means that the fees may only be allowed by the court if they are in proportion to the value of the claim. Experts must thus provide value for money. "Cancellation fees" and hourly rates of hundreds of pounds an hour will need robust justification. The rules allow the court to limit the amount that an expert is to be paid.
Despite these changes, the civil court system in England and Wales remains adversarial. This is slightly at odds with the court being advised by "neutral" experts, and it is questionable whether justice will be served by such a system. None the less, the use of website extra 
